ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 349644 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 349644; 2) Community: the network communities that were significantly associated with the response to NSC 349644; 3) Molecule: the relationships between components within communities and NSC 349644; 4) MDR: the compounds that were significantly associated with the NSC 349644.

NSC Compound Enrichment Correlation
NSC 166588 METHYLUNDECYLPIPERIDINE, TRANS 0.00423163567577551 0.57365687
NSC 23416 Null 0.00423163567577551 0.31098602
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.00423163567577551 0.21182568
NSC 321206 Null 0.00423163567577551 0.61533607
NSC 328785 ANTINEOPLASTIC-328785 0.00423163567577551 0.23416474
NSC 335789 3-Azabicyclo[3.2.1]nonane-3-carbothioic acid, [1-(6-methyl-2-pyridinyl)ethylidene]hydrazide 0.00423163567577551 0.3740765
NSC 335794 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)butylidene]hydrazide 0.00423163567577551 0.45603578
NSC 102810 D-ARABINOSE, 5-O-TRITYL-TRIBENZOATE 0.00457614317494024 0.55313546
NSC 169774 Bromocriptine methanesulfonate 0.00457614317494024 0.29273524
NSC 220334 Replaced CAS registry number(s): 66835-31-2 0.00457614317494024 0.52352854
Total:169  Current:38    [First] [Prev] [Next] [Last]